diflunisal and glucagon-like peptide 1

diflunisal has been researched along with glucagon-like peptide 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bech, EM; Jelsing, J; Jensen, KJ; Martos-Maldonado, MC; Pedersen, SL; Sørensen, KK; Thygesen, MB; van Witteloostuijn, SB; Vrang, N; Wismann, P	1

Other Studies

1 other study(ies) available for diflunisal and glucagon-like peptide 1

Article	Year
Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues. Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17 Topics: Albumins; Animals; Blood Glucose; Diflunisal; Drug Design; Eating; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Indomethacin; Mice, Inbred C57BL	2017

Article

Year

Peptide Half-Life Extension: Divalent, Small-Molecule Albumin Interactions Direct the Systemic Properties of Glucagon-Like Peptide 1 (GLP-1) Analogues.

Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17

Topics: Albumins; Animals; Blood Glucose; Diflunisal; Drug Design; Eating; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Half-Life; Hypoglycemic Agents; Indomethacin; Mice, Inbred C57BL

2017